The cell cycle regulator Cdh1 controls the pool sizes of hematopoietic stem cells and mature lineage progenitors by protecting from genotoxic stress
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-05-10
著者
-
Okamoto Shinichiro
Division Of Hematology Department Of Internal Medicane Keio University School Of Medicine
-
Nakajima Hideaki
Division Of Cellular Therapy Advanced Clinical Research Center The Institute Of Medical Science The
-
Yamamura Ken-ichi
Division Of Developmental Genetics Institute Of Molecular Embryology And Genetics Kumamoto Universit
-
Sugihara Eiji
Division Of Gene Regulation Institute For Advanced Medical Research Keio University School Of Medici
-
Saya Hideyuki
Division Of Gene Regulation Institute For Advanced Medical Research Keio University School Of Medici
-
Araki Kimi
Division Of Developmental Genetics Institute Of Molecular Embryology And Genetics Kumamoto Universit
-
Ikeda Yasuo
Life Science And Medical Bioscience Faculty Of Science And Engineering Waseda University
-
Kobayashi Yusuke
Division Of Gene Regulation Institute For Advanced Medical Research Department Of Medicine School Of
-
Nakajima Hideaki
Division Of Hematology Department Of Medicine School Of Medicine Keio University
-
Okamoto Shinichiro
Division Of Hematology Department Of Medicine School Of Medicine Keio University
-
ISHIZAWA Jo
Division of Gene Regulation, Institute for Advanced Medical Research, Department of Medicine, School
-
KUNINAKA Shinji
Division of Gene Regulation, Institute for Advanced Medical Research, Department of Medicine, School
-
NAOE Hideaki
Division of Gene Regulation, Institute for Advanced Medical Research, Department of Medicine, School
-
CHIYODA Tatsuyuki
Division of Gene Regulation, Institute for Advanced Medical Research, Department of Medicine, School
-
UEKI Arisa
Division of Gene Regulation, Institute for Advanced Medical Research, Department of Medicine, School
-
MATSUZAKI Yumi
Division of Physiology, School of Medicine, Keio University
-
Yamamura Ken-ichi
Division Of Organogenesis Institute Of Molecular Embryology And Genetics School Of Medicine Kumamoto
-
Ueki Arisa
Division Of Gene Regulation Institute For Advanced Medical Research Department Of Medicine School Of
-
Kuninaka Shinji
Division Of Gene Regulation Institute For Advanced Medical Research Department Of Medicine School Of
-
Sugihara Eiji
Division Of Gene Regulation Institute For Advanced Medical Research Department Of Medicine School Of
-
Ishizawa Jo
Division Of Gene Regulation Institute For Advanced Medical Research Department Of Medicine School Of
-
Chiyoda Tatsuyuki
Division Of Gene Regulation Institute For Advanced Medical Research Department Of Medicine School Of
-
Naoe Hideaki
Division Of Gene Regulation Institute For Advanced Medical Research Department Of Medicine School Of
-
Saya Hideyuki
Division Of Gene Regulation Institute For Advanced Medical Research Department Of Medicine School Of
-
Matsuzaki Yumi
Division Of Physiology School Of Medicine Keio University
-
Araki Kimi
Division Of Developmental Genetics Center For Animal Resources And Development Kumamoto University
-
Araki Kimi
Division Of Organogenesis Institute Of Molecular Embryology And Genetics School Of Medicine Kumamoto University
関連論文
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- Effect of the Intestinal Flora on Amyloid Deposition in a Transgenic Mouse Model of Familial Amyloidotic Polyneuropathy
- Aplastic Anemia
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Non-Tuberculous Mycobacterial Infection Localized in Small Intestine Developing after Allogeneic Bone Marrow Transplantation
- Gelatinous Degeneration in a Recipient of Allogeneic Bone Marrow Transplantation
- Overcoming the effect of rifampin on the tacrolimus metabolism by itraconazole administration in an allogeneic hematopoietic stem cell transplant recipient
- Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients : an association with bioavailability of oral solution itraconazole
- CD44^+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E_2 in gastric tumorigenesis
- Prevention of Cytomegalovirus Infection by Valaciclovir after Allogeneic Bone Marrow Transplantation from an Unrelated Donor
- Risk-Adapted Preemptive Therapy for Cytomegalovirus Diseases after Allogeneic Hematopoietic Stem Cell Transplantation
- A Flare-Up of Chronic Graft-versus-Host Disease of the Liver That Mimics Acute Hepatitis in a Recipient of an Allogeneic Peripheral Blood Stem Cell Transplant
- Thalidomide-Induced Severe Neutropenia during Treatment of Multiple Myeloma
- Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation
- Esophageal varices and portal hypertensive gastropathy associated with hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation
- Recurrence of Autoimmune Disease after Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
- Multilineage Involvement of Light Microscopic Myeloperoxidase-Negative Acute Leukemia
- Thalidomide for the Treatment of Refractory Multiple Myeloma : Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome
- Elevated Level of Plasma Basic Fibroblast Growth Factor in Multiple Myeloma Correlates with Increased Disease Activity
- Renoprotective effects of angiotensin II receptor blocker, candesartan cilexetil, in patients with stage 4-5 chronic kidney disease
- Targeted Retrograde Transfection of Adenovirus Vector Carrying Brain-Derived Neurotrophic Factor Gene Prevents Loss of Mouse (twy/twy) Anterior Horn Neurons In Vivo Sustaining Mechanical Compression
- Multivariate analysis of the neurological outcome of surgery for cervical compressive myelopathy
- Current and future perspectives on the TARGET system : the registration system for Glivec^【○!R】 established by the JSH
- Central line-associated bacteremia caused by drug-resistant Staphylococcus caprae after chemotherapy for acute myelogenous leukemia
- An Adult Patient With Hypersensitivity to Mosquito Bites Developing Mantle Cell Lymphoma
- Possible involvement of RasGRP4 in leukemogenesis
- Mouse mammary gland reconstitution with extrinsic gene-transferred mammary epithelial cells in vitro and in vivo
- Successful Treatment of Adult Onset Langerhans Cell Histiocytosis with Multi-Drug Combination Therapy
- Breast cancer stem cells
- Presence and distribution of neural crest-derived cells in the murine developing thymus and their potential for differentiation
- Overexpression of Interleukin 21 Induces Expansion of Hematopoietic Progenitor Cells
- Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model
- Hemorrhagic colonic ulcers caused by dasatinib for chronic myelogenous leukemia
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Erythroid Crisis Caused by Parvovirus B19 Transmitted Via Red Blood Cell Transfusion
- The cell cycle regulator Cdh1 controls the pool sizes of hematopoietic stem cells and mature lineage progenitors by protecting from genotoxic stress
- The role of a real-time PCR technology for rapid detection and identification of bacterial and fungal pathogens in whole-blood samples
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
- Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
- Role of Transcription Factors in Differentiation and Reprogramming of Hematopoietic Cells
- Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients : a double-blind, randomized Phase III clinical trial
- Discrepancy in the kinetics of total and active anti-thymocyte globulin blood concentrations in recipients of allogeneic hematopoietic stem cell transplantation
- Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation
- Prospective study of combination therapy with low-dose thalidomide plus prednisolone ameliorating cytopenia in primary myelofibrosis
- Prevention of cytarabine-induced kerato-conjunctivitis by eye rinse in patients receiving high-dose cytarabine and total body irradiation as a conditioning for hematopoietic stem cell transplantation
- Nifedipine increases energy expenditure by increasing PGC-1α expression in skeletal muscle
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation
- Pancytopenia due to pyrimethamine triggered by transplant-associated microangiopathy after allogeneic bone marrow transplantation
- An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)
- Gene trap mutagenesis in mice : New perspectives and tools in cancer research
- Post-transplant consolidation therapy using thalidomide alone for the patients with multiple myeloma : a feasibility study in Japanese population
- Itraconazole may increase the risk of early-onset bortezomib-induced peripheral neuropathy
- Transformation of Myelodysplastic Syndrome to Acute Lymphoblastic Leukemia : A Case Report and Review of the Literature
- Validation of NIH consensus criteria for diagnosis and severity-grading of chronic graft-versus-host disease